The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis

Salim S. Virani; Vijay Nambi

doi:10.1007/s11883-007-0004-9

The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis

Salim S. Virani, Vijay Nambi

Office of the Provost

Research output: Contribution to journal › Review article › peer-review

18 Citations (Scopus)

Abstract

Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an enzyme that belongs to the superfamily of phospholipase A2 enzymes. Although initial studies showed that Lp-PLA2 might be protective against atherosclerosis, emerging data seem to suggest that Lp-PLA2 may be proatherogenic, which is an effect thought to be mediated by lysophosphatidylcholine and oxidized nonesterified fatty acids, two mediators generated by Lp-PLA2. This article reviews the potential mechanisms by which Lp-PLA2 may participate in the pathogenesis of atherosclerosis and its clinical manifestations, namely, coronary artery disease and stroke.

Original language	English (UK)
Pages (from-to)	97-103
Number of pages	7
Journal	Current Atherosclerosis Reports
Volume	9
Issue number	2
DOIs	https://doi.org/10.1007/s11883-007-0004-9
Publication status	Published - Aug 2007

Access to Document

10.1007/s11883-007-0004-9

Cite this

@article{64a130b640ad4f08af491facb1fd3921,

title = "The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis",

abstract = "Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an enzyme that belongs to the superfamily of phospholipase A2 enzymes. Although initial studies showed that Lp-PLA2 might be protective against atherosclerosis, emerging data seem to suggest that Lp-PLA2 may be proatherogenic, which is an effect thought to be mediated by lysophosphatidylcholine and oxidized nonesterified fatty acids, two mediators generated by Lp-PLA2. This article reviews the potential mechanisms by which Lp-PLA2 may participate in the pathogenesis of atherosclerosis and its clinical manifestations, namely, coronary artery disease and stroke.",

author = "Virani, \{Salim S.\} and Vijay Nambi",

year = "2007",

month = aug,

doi = "10.1007/s11883-007-0004-9",

language = "English (UK)",

volume = "9",

pages = "97--103",

journal = "Current Atherosclerosis Reports",

issn = "1523-3804",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis

AU - Virani, Salim S.

AU - Nambi, Vijay

PY - 2007/8

Y1 - 2007/8

N2 - Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an enzyme that belongs to the superfamily of phospholipase A2 enzymes. Although initial studies showed that Lp-PLA2 might be protective against atherosclerosis, emerging data seem to suggest that Lp-PLA2 may be proatherogenic, which is an effect thought to be mediated by lysophosphatidylcholine and oxidized nonesterified fatty acids, two mediators generated by Lp-PLA2. This article reviews the potential mechanisms by which Lp-PLA2 may participate in the pathogenesis of atherosclerosis and its clinical manifestations, namely, coronary artery disease and stroke.

AB - Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an enzyme that belongs to the superfamily of phospholipase A2 enzymes. Although initial studies showed that Lp-PLA2 might be protective against atherosclerosis, emerging data seem to suggest that Lp-PLA2 may be proatherogenic, which is an effect thought to be mediated by lysophosphatidylcholine and oxidized nonesterified fatty acids, two mediators generated by Lp-PLA2. This article reviews the potential mechanisms by which Lp-PLA2 may participate in the pathogenesis of atherosclerosis and its clinical manifestations, namely, coronary artery disease and stroke.

UR - https://www.scopus.com/pages/publications/34548476009

U2 - 10.1007/s11883-007-0004-9

DO - 10.1007/s11883-007-0004-9

M3 - Review article

C2 - 17877917

AN - SCOPUS:34548476009

SN - 1523-3804

VL - 9

SP - 97

EP - 103

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

IS - 2

ER -

The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis

Abstract

Access to Document

Other files and links

Fingerprint

Cite this